Stockscreener 앱 받기
1.46
8.18%
-0.13
시간 외 거래:
1.50
0.04
+2.74%
전일 마감가:
$1.59
열려 있는:
$1.55
하루 거래량:
4.34M
Relative Volume:
0.81
시가총액:
$231.90M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-1.3645
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
-14.12%
1개월 성능:
-30.48%
6개월 성능:
+11.45%
1년 성능:
-71.20%
1일 변동 폭
$1.46
$1.5584
1주일 범위
$1.46
$1.78
52주 변동 폭
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.46 | 297.76M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-27 | 개시 | Barclays | Overweight |
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Will Humacyte Inc. see short term momentumEarnings Overview Summary & AI Driven Price Predictions - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buying2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Using data models to predict Humacyte Inc. Equity Warrant stock movementJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Is Humacyte Inc. Equity Warrant stock vulnerable to regulatory risksShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Quantitative breakdown of Humacyte Inc. recent moveMarket Activity Recap & Weekly Momentum Picks - newser.com
Will Humacyte Inc. stock attract more institutional investorsMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Market reaction to Humacyte Inc.’s recent newsEarnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakout2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Tick level data insight on Humacyte Inc. Equity Warrant volatility2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Is Humacyte Inc. stock supported by strong cash flowsPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Volume spikes in Humacyte Inc. Equity Warrant stock – what they mean - newser.com
Real time pattern detection on Humacyte Inc. stockWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Can Humacyte Inc. stock reach $100 price targetEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Can Humacyte Inc. Equity Warrant stock deliver consistent earnings growthDividend Hike & Weekly Breakout Watchlists - newser.com
Will Humacyte Inc. stock deliver shareholder value2025 Price Action Summary & Fast Entry Momentum Alerts - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFs2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Why Humacyte Inc. Equity Warrant stock could outperform in 2025July 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-03 03:47:12 - newser.com
Why Humacyte Inc. stock remains on buy listsJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Key metrics from Humacyte Inc.’s quarterly dataLayoff News & Smart Swing Trading Techniques - newser.com
Tick level data insight on Humacyte Inc. volatilityTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday? - AOL.com
Is Humacyte Inc. stock trading near support levels2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
What recovery options are there for Humacyte Inc. Equity WarrantQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Technical analysis overview for Humacyte Inc. Equity Warrant stockCPI Data & Advanced Technical Analysis Signals - newser.com
How Humacyte Inc. Equity Warrant stock performs in high volatility marketsEarnings Recap Report & Weekly High Conviction Ideas - newser.com
Is now a turning point for Humacyte Inc. Equity WarrantWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Predicting Humacyte Inc. trend using moving averages2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Multi asset correlation models including Humacyte Inc. Equity Warrant2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Earnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Chart overlay techniques for tracking Humacyte Inc.July 2025 Snapshot & Community Verified Trade Alerts - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Is Humacyte Inc. Equity Warrant stock a dividend growth opportunityJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Earnings visualization tools for Humacyte Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Humacyte rises on Symvess sale to military treatment facility - MSN
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):